Suppr超能文献

附加口服奥氮平会加重分裂情感性障碍中的幻觉症状。

Add-on oral olanzapine worsens hallucinations in schizoaffective disorder.

作者信息

Volpe Umberto, Vignapiano Annarita, Gallo Olimpia, Fabrazzo Michele

机构信息

Department of Psychiatry, University of Naples SUN, Naples, Italy.

出版信息

BMJ Case Rep. 2014 Oct 21;2014:bcr2014205805. doi: 10.1136/bcr-2014-205805.

Abstract

Anecdotal evidence tends to favour olanzapine in the treatment of hallucinations in patients with schizophrenia spectrum disorders; however, no conclusive evidence is available on this topic. We report here a clinical case in which a 46-year-old man, suffering from a schizoaffective disorder (depressed type), underwent olanzapine treatment (20 mg/day). After inducing an initial amelioration, the patient had a re-exacerbation of auditory hallucinations and a clinical and psychosocial worsening, which subsided after olanzapine discontinuation. Olanzapine may induce a worsening of hallucinations in a psychotic disorder with substantial affective component and therefore its use should be carefully evaluated in such cases.

摘要

轶事证据倾向于支持奥氮平治疗精神分裂症谱系障碍患者的幻觉;然而,关于这一主题尚无确凿证据。我们在此报告一例临床病例,一名46岁患有分裂情感障碍(抑郁型)的男性接受了奥氮平治疗(20毫克/天)。在最初症状改善后,患者出现幻听再次加重以及临床和社会心理状况恶化,在停用奥氮平后这些症状缓解。奥氮平可能会使具有显著情感成分的精神障碍中的幻觉恶化,因此在这类病例中使用时应仔细评估。

相似文献

1
Add-on oral olanzapine worsens hallucinations in schizoaffective disorder.
BMJ Case Rep. 2014 Oct 21;2014:bcr2014205805. doi: 10.1136/bcr-2014-205805.
3
Olanzapine and delirium: lesson from clinical practice.
Aust N Z J Psychiatry. 2008 May;42(5):433-4.
7
Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
J Clin Psychiatry. 2001 Jul;62(7):509-16. doi: 10.4088/jcp.v62n07a02.
8
Olanzapine treatment of eight adolescent patients with psychosis.
Hum Psychopharmacol. 2004 Jan;19(1):53-6. doi: 10.1002/hup.547.

本文引用的文献

2
The treatment of hallucinations in schizophrenia spectrum disorders.
Schizophr Bull. 2012 Jun;38(4):704-14. doi: 10.1093/schbul/sbs034. Epub 2012 Feb 24.
3
Auditory verbal hallucinations and cognitive functioning in healthy individuals.
Schizophr Res. 2011 Nov;132(2-3):203-7. doi: 10.1016/j.schres.2011.07.013. Epub 2011 Aug 12.
4
Olanzapine versus other atypical antipsychotics for schizophrenia.
Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD006654. doi: 10.1002/14651858.CD006654.pub2.
6
Effect of valproate on olanzapine plasma concentrations in patients with bipolar or schizoaffective disorder.
Ther Drug Monit. 2009 Dec;31(6):758-63. doi: 10.1097/FTD.0b013e3181c0590e.
7
Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature.
Neuropsychiatr Dis Treat. 2008 Dec;4(6):1089-109. doi: 10.2147/ndt.s4120.
8
Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
Psychol Med. 2009 Oct;39(10):1591-602. doi: 10.1017/S0033291709005455. Epub 2009 Apr 1.
9
Proposal for a new tool to evaluate drug interaction cases.
Ann Pharmacother. 2007 Apr;41(4):674-80. doi: 10.1345/aph.1H423. Epub 2007 Mar 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验